Pyrans
Medchemexpress LLC 17-carboxy budesonide | 192057-49-1 | 50mg
17-Carboxy Budesonide is a Budesonide (HY-13580) impurity
Selleck Chemical LLC MF-438
MF-438 is a potent and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor with IC50 of 2 3 nM for rSCD1
Medchemexpress LLC (2R)-octyl-α-hydroxyglutarate | 1391194-67-4 | 99.9% | 260.33 g/mol | C13H24O5 | 25 MG
(2R)-Octyl-α-hydroxyglutarate is the octyl ester derivative of 2-hydroxyglutarate used in biochemical and cell-based research. It is supplied as a white to off-white solid with high purity and documented solubility and storage guidelines for experimental use.
- Solid white to off-white appearance
- High purity (≈99.9%)
- Molecular weight 260.33 g/mol; formula C13H24O5
- Soluble in DMSO (100 mg/mL) and formulatable for in vivo use
- Stable under recommended storage: 4°C sealed; in solvent -80°C (6 months)
- Available in milligram-scale quantities including 25 mg
eMolecules ChemScene 2-(Tetrahydro-2H-pyran-2-yl)-4-(4 4 5 5-tetramethyl-1 3 2-dioxaborolan-2-yl)-2H-1 2 3-triazole 250mg 686071978 CS-0201982 0 000 1415312-45-6 MFCD26521334 279 150 C13H22BN3O3
ChemScene 2-(Tetrahydro-2H-pyran-2-yl)-4-(4 4 5 5-tetramethyl-1 3 2-dioxaborolan-2-yl)-2H-1 2 3-triazole 250mg 686071978 CS-0201982 0 000 1415312-45-6 MFCD26521334 279 150 C13H22BN3O3
eMolecules J W PharmLab LLC 2-(Tetrahydro-pyran-2-yl)-4-(4 4 5 5-tetramethyl-[1 3 2]dioxaborolan-2-yl)-2H-[1 2 3]triazole 250mg 529045991 32R0304P 96 000 1415312-45-6 MFCD26521334 279 150 C13H22BN3O3
J W PharmLab LLC 2-(Tetrahydro-pyran-2-yl)-4-(4 4 5 5-tetramethyl-[1 3 2]dioxaborolan-2-yl)-2H-[1 2 3]triazole 250mg 529045991 32R0304P 96 000 1415312-45-6 MFCD26521334 279 150 C13H22BN3O3
Apexbio Technology LLC Carboxy-PTIO, potassium salt 10mg
Carboxy-PTIO potassium salt (CAS 148819-94-7) is a small molecule recognized as a nitric oxide (NO) scavenger It reacts rapidly with NO converting it to nitrogen oxides and thereby reducing bioavailable NO levels In lipopolysaccharide-induced rat models administration of Carboxy-PTIO potassium salt has been shown to attenuate hypotension and decrease the incidence of endotoxic shock via NO clearance This compound is widely employed in studies investigating NO-related signaling pathways and the pathophysiological roles of aberrant NO production